EDGAR Filing Documents for 0001431373-09-000002

Form 4 - Statement of changes in beneficial ownership of securities:

SEC Accession No. 0001431373-09-000002

Filing Date

2009-02-20

Accepted

2009-02-20 14:17:13

Documents

Period of Report

2009-02-18

Document Format Files

Seq	Description	Document	Type	Size
1	PRIMARY DOCUMENT	edgar.html	4
1	PRIMARY DOCUMENT	edgar.xml	4	10460
	Complete submission text file	0001431373-09-000002.txt		12281

Mailing Address 929 NORTH FRONT STREET WILMINGTON NC 28401

Business Address 929 NORTH FRONT STREET WILMINGTON NC 28401 9102510081

PHARMACEUTICAL PRODUCT DEVELOPMENT INC (Issuer) CIK: 0001003124 (see all company filings)

IRS No.: 561640186 | State of Incorp.: NC | Fiscal Year End: 1231
SIC: 8731 Services-Commercial Physical & Biological Research

Mailing Address 929 NORTH FRONT STREET WILMINGTON NC 28401

Business Address 910.251.0081

Type: 4 | Act: 34 | File No.: 000-27570 | Film No.: 09624585